Rybelsus is the brand name for semaglutide, a popular medicine used to treat Type 2 diabetes and promote weight loss. If you are diabetic, you probably have Rybelsus somewhere in your medicine cabinet. You have it — or were using it before — because you trusted everything, the company told you about it. But this company didn't tell you that semaglutide can increase your chances of developing a "paralyzed stomach", a condition doctors call gastroparesis. So if you're wondering why you or a loved one has been falling violently ill with stomach-related complications, it's probably because someone somewhere did not disclose the full Rybelsus side effects you should have known before purchasing this medicine.
That is the reason multiple lawsuits are now being filed against Novo Nordisk, the manufacturer of Rybelsus. Contact us today if you believe you were harmed by this medicine. You might be eligible for compensation.